The Clariom GO Screen Assay is a transcriptome profiling solution that provides a high-throughput, low-cost method to directly measure the expression of ~20,000 genes. With relevant probes derived from the Gene Ontology (GO) Consortium and content developed in collaboration with pharmaceutical researchers, this assay helps you quickly assess changes in key genes and pathways. Whether you want to accelerate the development of new drug compounds, reduce reliance on animal testing for toxicological research, examine cellular response to cosmetic or skincare formulations, or rapidly identify immune-response pathways involved in novel infectious diseases such as SARS-CoV-2, Clariom GO Screen Assay is a reliable, low-cost platform that speeds your time from experiment to analysis.